Obstetric and perinatal outcome of the women with repeated implantation failures or recurrent pregnancy losses who received pre- and post-conception tacrolimus treatment.

Koji NakagawaJoanne Kwak-KimMichi HisanoYoshimitsu KasaharaKeiji KurodaRikikazu SugiyamaKoushi Yamaguchi

Published in: American journal of reproductive immunology (New York, N.Y. : 1989) (2019)

According to our data, tacrolimus treatment for women with RIF and RPL was not associated with obstetrical and perinatal complications. A large size study is needed to confirm this finding.

Keyphrases

pregnant women
risk factors
pulmonary tuberculosis
preterm birth
combination therapy
big data
electronic health record
replacement therapy
pregnancy outcomes
artificial intelligence
data analysis